EPO Patent: Selective Regulatory Gene System for Genetically Modified Immune Cell Therapy
Summary
The European Patent Office has published patent application EP4502162A1 concerning a Selective Regulatory Gene (SRG) System for Genetically Modified Immune Cell Therapy. The patent application lists Jichi Medical University and Takara Bio Inc. as applicants.
What changed
The European Patent Office (EPO) has published patent application EP4502162A1, titled 'Selective Regulatory Gene (SRG) System for Genetically Modified Immune Cell Therapy'. This application, filed by Jichi Medical University and Takara Bio Inc., details a novel system for controlling gene expression in genetically modified immune cells, potentially impacting the development and application of advanced cell therapies.
As this is a patent publication, it does not impose direct regulatory obligations or compliance deadlines on entities. However, companies involved in the development of cell therapies, particularly those utilizing genetic modification techniques, should be aware of this patent as it may affect intellectual property landscapes and future research and development strategies in the field of immunotherapy.
Source document (simplified)
SELECTIVE REGULATORY GENE (SRG) SYSTEM FOR GENETICALLY MODIFIED IMMUNE CELL THERAPY
Publication EP4502162A1 Kind: A1 Mar 18, 2026
Applicants
Jichi Medical University, Takara Bio Inc.
Inventors
UCHIBORI, Ryosuke, OHMINE, Ken, OZAWA, Keiya
IPC Classifications
C12N 15/62 20060101AFI20260210BHEP A61K 35/12 20150101ALI20260210BHEP A61P 35/00 20060101ALI20260210BHEP C07K 14/715 20060101ALI20260210BHEP C07K 19/00 20060101ALI20260210BHEP C12N 5/0783 20100101ALI20260210BHEP C12N 5/10 20060101ALI20260210BHEP C12N 15/12 20060101ALI20260210BHEP C12N 15/63 20060101ALI20260210BHEP A61K 40/31 20250101ALI20260210BHEP A61K 40/42 20250101ALI20260210BHEP C07K 14/71 20060101ALI20260210BHEP A61K 40/11 20250101ALI20260210BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.